Navidea Biopharmaceuticals P/CF Ratio | NAVB

Annual P/CF Ratio Navidea Biopharmaceuticals

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008
-0.997	-2.79	-6.37	-1.85	128	19.7	481	-132	-164	-120	-272	-305	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
481	-305	-31.5

P/CF Ratio of other stocks in the Biotechnology industry

Issuer	P/CF Ratio	Price	% 24h	Market Cap	Country
AnaptysBio ANAB	-30.3	$ 51.7	1.83 %	$ 1.5 B	USA
Allakos ALLK	-0.976	-	-	$ 28.6 M	USA
Bicycle Therapeutics plc BCYC	-1.41	$ 3.73	3.61 %	$ 258 M	Britain
Black Diamond Therapeutics BDTX	4.21	$ 1.89	0.53 %	$ 107 M	USA
Clovis Oncology CLVS	-1.34	-	-7.23 %	$ 13 M	USA
Concert Pharmaceuticals CNCE	-1.89	-	-	$ 401 M	USA
Rezolute RZLT	-6.33	$ 3.94	1.87 %	$ 299 M	USA
Evelo Biosciences EVLO	-0.267	-	-14.46 %	$ 27.9 M	USA
BioLineRx Ltd. BLRX	-699	$ 2.52	1.17 %	$ 6.21 B	Israel
BioMarin Pharmaceutical BMRN	14.1	$ 61.35	0.06 %	$ 11.8 B	USA
Benitec Biopharma BNTC	-34	$ 9.64	0.46 %	$ 449 M	USA
BioNTech SE BNTX	48.3	$ 99.26	0.81 %	$ 24 B	Germany
Freeline Therapeutics Holdings plc FRLN	-3.33	-	-	$ 384 M	Britain
Genocea Biosciences GNCA	-1.6	-	-15.0 %	$ 3.04 M	USA
Burford Capital Limited BUR	-95.9	$ 3.63	3.93 %	$ 795 M	Britain
Amryt Pharma plc AMYT	164	-	-	$ 621 M	Britain
G1 Therapeutics GTHX	-4.52	-	-	$ 370 M	USA
Can-Fite BioPharma Ltd. CANF	-0.537	$ 2.17	0.46 %	$ 3.57 M	Israel
Catalyst Biosciences CBIO	989	$ 14.24	0.35 %	$ 1.27 B	USA
C4 Therapeutics CCCC	-2.37	$ 3.03	0.3 %	$ 251 M	USA
Codexis CDXS	-5.71	$ 1.37	1.45 %	$ 119 M	USA
Cerus Corporation CERS	102	$ 2.61	0.38 %	$ 497 M	USA
AbbVie ABBV	21	$ 265.12	0.09 %	$ 469 B	USA
Humanigen HGEN	-0.163	-	-81.12 %	$ 4.28 M	USA
Coherus BioSciences CHRS	-1.63	$ 1.17	1.48 %	$ 137 M	USA
AbCellera Biologics ABCL	-7.33	$ 12.65	2.76 %	$ 3.78 B	Canada
Abeona Therapeutics ABEO	-3.3	$ 5.43	2.65 %	$ 288 M	USA
Celldex Therapeutics CLDX	-9.67	$ 31.48	1.16 %	$ 2.09 B	USA
CollPlant Biotechnologies Ltd. CLGN	-0.492	$ 4.12	1.98 %	$ 50.3 M	Israel
Фармсинтез LIFE	-8.26	-	-	-	Russia
Cellectar Biosciences CLRB	-0.324	$ 2.08	0.48 %	$ 5.43 M	USA
IGM Biosciences IGMS	-0.554	-	-	$ 76.9 M	USA
IMV IMV	-0.195	-	-	$ 13.1 M	Canada
Kinnate Biopharma KNTE	-1.24	-	-	$ 123 M	USA
Checkmate Pharmaceuticals CMPI	-0.982	-	-	$ 231 M	USA
Karuna Therapeutics KRTX	-30.5	-	-	$ 12.2 B	USA
Cocrystal Pharma COCP	-1.39	$ 1.15	1.67 %	$ 13 M	USA
Crinetics Pharmaceuticals CRNX	-10.9	$ 84.95	0.13 %	$ 7.99 B	USA
Collegium Pharmaceutical COLL	4.25	$ 22.64	0.85 %	$ 717 M	USA
Corcept Therapeutics Incorporated CORT	26.4	$ 118.51	4.93 %	$ 12.3 B	USA
Chimerix CMRX	-1.5	-	-	$ 756 M	USA
Corbus Pharmaceuticals Holdings CRBP	-1.97	$ 7.45	0.19 %	$ 99.2 M	USA
Curis CRIS	-0.348	$ 0.88	0.85 %	$ 11.6 M	USA
CorMedix CRMD	0.0026	$ 7.77	1.04 %	$ 560 K	USA
CRISPR Therapeutics AG CRSP	-12.7	$ 55.7	0.23 %	$ 5.01 B	Schweiz
Corvus Pharmaceuticals CRVS	-9.7	$ 11.8	8.21 %	$ 932 M	USA
Champions Oncology CSBR	-18.7	$ 4.95	0.38 %	$ 68.5 M	USA
Arbutus Biopharma Corporation ABUS	-21.4	$ 4.88	0.62 %	$ 935 M	Canada
Cue Biopharma CUE	-1.35	$ 32.85	3.6 %	$ 3.11 B	USA
CEL-SCI Corporation CVM	-1.16	$ 1.72	2.38 %	$ 13.8 M	USA